Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [06/11/2019 13:21 PDT] Tenax Therapeutics, Inc. (NASDAQ:TENX), Up By 100.00% ($1.45) From $1.450 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/23/2019 07:46 PDT] TENX Expected to Trade Down After Bearish Patterns Develop
• [05/23/2019 07:45 PDT] TENX Expected to Trade Up After Bullish Patterns Develop
• [04/30/2019 07:51 PDT] TENX Expected to Trade Up After Bullish Patterns Develop